Found 427 matching trials
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression PHASE2 The purpose of this study is to find out if there is a benefit of adding He...
Show More Location
Hays Medical Center
Learn More & Join Trial
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer PHASE2 This pilot study is evaluating how well pembrolizumab and combination chemo...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma PHASE2 Study of ONTAK and CHOP (chemotherapy drugs) to find out their ability to m...
Show More Location
Birmingham Hematology and Oncology
Learn More & Join Trial
Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer PHASE1 RATIONALE: Drugs used in chemotherapy such as epirubicin and docetaxel use ...
Show More Location
CancerCare Manitoba
Learn More & Join Trial
Cabozantinib With Topotecan-Cyclophosphamide PHASE1 This research study is a clinical trial of a new combination of drugs as a ...
Show More Location
Boston Children's Hospital
Learn More & Join Trial
Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma PHASE2 The goal of this clinical research study is to learn if intensive chemother...
Show More Location
The University of Texas M. D. Anderson Cancer Center
Learn More & Join Trial
Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder PHASE1 To evaluate the safety and feasibility of collecting hematopoietic stem cel...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL PHASE3 This compares the effects of nivolumab at a fixed dose of 40 mg with chemo-...
Show More Location
National Research Center for Hematology
Learn More & Join Trial
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients PHASE3 This is a prospective, randomized, two-arm, multicenter, exploratory study ...
Show More Location
Dongyang People's Hospital
Learn More & Join Trial
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) N/A The purpose of this research study is to evaluate the safety and effectiven...
Show More Location
Multiple Locations
Learn More & Join Trial